Roivant Sciences Ltd.
ROIV
$11.92
$0.110.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.50B | 4.89B | 5.15B | 5.39B | 5.68B |
| Total Receivables | -- | -- | 143.78M | 22.68M | 215.22M |
| Inventory | -- | -- | -- | -- | 34.00M |
| Prepaid Expenses | -- | -- | 57.66M | 54.84M | 57.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 112.60M | 113.17M | 16.02M | 336.94M | 16.49M |
| Total Current Assets | 4.62B | 5.00B | 5.36B | 5.80B | 6.00B |
|
|
|||||
| Total Current Assets | 4.62B | 5.00B | 5.36B | 5.80B | 6.00B |
| Net Property, Plant & Equipment | 101.94M | 101.08M | 104.46M | 56.65M | 63.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 136.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.09M | 32.86M | 33.88M | 36.90M | 32.81M |
| Total Assets | 5.03B | 5.44B | 5.79B | 6.21B | 6.50B |
|
|
|||||
| Total Accounts Payable | 11.55M | 23.69M | 23.71M | 25.13M | 27.74M |
| Total Accrued Expenses | 88.73M | 114.29M | 104.32M | 111.47M | 138.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.40M | 9.84M | 9.84M | 9.52M | 21.49M |
| Total Finance Division Other Current Liabilities | 4.19M | 1.58M | 3.61M | 410.13M | 27.53M |
| Total Other Current Liabilities | 4.19M | 1.58M | 3.61M | 410.13M | 27.53M |
| Total Current Liabilities | 113.87M | 149.41M | 141.48M | 556.25M | 215.05M |
|
|
|||||
| Total Current Liabilities | 113.87M | 149.41M | 141.48M | 556.25M | 215.05M |
| Long-Term Debt | -- | -- | -- | -- | 311.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.29M | 90.33M | 90.48M | 43.19M | 45.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.54M | 10.00M | 24.41M | 26.55M | 28.55M |
| Total Liabilities | 216.70M | 249.74M | 256.38M | 625.99M | 601.16M |
|
|
|||||
| Common Stock & APIC | 4.64B | 4.56B | 4.72B | 4.78B | 4.78B |
| Retained Earnings | -315.59M | 116.06M | 460.40M | 395.58M | 671.47M |
| Treasury Stock & Other | 17.14M | 9.44M | 8.06M | -18.04M | -17.95M |
| Total Common Equity | 4.35B | 4.69B | 5.19B | 5.15B | 5.44B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.35B | 4.69B | 5.19B | 5.15B | 5.44B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 470.27M | 499.59M | 346.50M | 427.09M | 459.98M |
| Total Equity | 4.82B | 5.19B | 5.54B | 5.58B | 5.90B |
|
|
|||||